These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 741450)

  • 1. Fractionated tritium-labelled heparin studied in vitro and in vivo.
    Shanberge JN; Gruhl M; Kitani T; Ambegaonkar S; Kambayashi J; Nakagawa M; Lenter D
    Thromb Res; 1978 Nov; 13(5):767-83. PubMed ID: 741450
    [No Abstract]   [Full Text] [Related]  

  • 2. Fractionation of heparin by chromatography on immobilized thrombin. Correlation between the anticoagulant activity of the fractions and their content of heparin with high affinity for antithrombin.
    Nordenman B; Björk I
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):711-8. PubMed ID: 7444870
    [No Abstract]   [Full Text] [Related]  

  • 3. 3H-heparin and antithrombin III in the isolated liver perfusion.
    Losito R; Barlow G; Lemieux E
    Thromb Res; 1977 Jan; 10(1):83-93. PubMed ID: 850904
    [No Abstract]   [Full Text] [Related]  

  • 4. Biophysical characteristics of anionic density-fractionated mucosal heparins in relation to potencies in anticoagulant and thrombin-inhibition assays.
    Hurst RE; van Dedem G; Settine JM
    Thromb Res; 1981 Jun 1-25; 22(5-6):633-43. PubMed ID: 7302907
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin, platelets and blood coagulation: implications for low-dose heparin prophylactic regimens in venous thrombosis.
    Han P; Ardlie NG
    Br J Haematol; 1974 Jun; 27(2):253-72. PubMed ID: 4843673
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism and anticoagulant effect of 51Cr-labelled heparin.
    Alánt O; Varga L; Antoni F; Karácsonyi S; Faller J
    Acta Physiol Acad Sci Hung; 1973; 43(3):261-7. PubMed ID: 4790805
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombin III and heparin.
    Barrowcliffe TW; Johnson EA; Thomas D
    Br Med Bull; 1978 May; 34(2):143-50. PubMed ID: 350337
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative activities of heparin fractions obtained by gel chromatography.
    Graham DT; Pomeroy AR
    Thromb Haemost; 1980 Feb; 42(5):1598-603. PubMed ID: 7368160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of protamine on heparin-antithrombin III complexes. In vitro studies.
    Kitani T; Nagarajan SC; Shanberge JN
    Thromb Res; 1980 Feb 1-15; 17(3-4):367-74. PubMed ID: 7368168
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration.
    Andersson LO; Barrowcliffe TW; Holmer E; Johnson EA; Sims GE
    Thromb Res; 1976 Dec; 9(6):575-83. PubMed ID: 1006626
    [No Abstract]   [Full Text] [Related]  

  • 11. On the complex formation of antithrombin 3 with thrombin. Gelfiltration studies on human plasma and serum.
    Binder B
    Thromb Diath Haemorrh; 1973 Nov; 30(2):280-3. PubMed ID: 4589772
    [No Abstract]   [Full Text] [Related]  

  • 12. Macromolecule-macromolecule interaction in drug distribution. II. Effect of alpha-globulin on saturable uptake of fractionated [3H]heparin by rat parenchymal hepatocytes in primary culture.
    Watanabe J; Muranishi H; Yuasa H; Ozeki S
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3052-5. PubMed ID: 1282443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions and interactions of antithrombin and heparin.
    Rosenberg RD
    N Engl J Med; 1975 Jan; 292(3):146-51. PubMed ID: 127943
    [No Abstract]   [Full Text] [Related]  

  • 14. Uptake of fluorescein isothiocyanate (FITC)-fractionated heparin by rat parenchymal hepatocytes in primary culture.
    Watanabe J; Muranishi H; Haba M; Yuasa H
    Biol Pharm Bull; 1993 Sep; 16(9):939-41. PubMed ID: 8268865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and the progressive anti-thrombin activity of alpha 2-macroglobulin.
    Pochon F; Lambin P; Steinbuch M
    Thromb Res; 1982 Jun; 26(5):307-16. PubMed ID: 6187083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of fractionated 3H-heparin in rats.
    Watanabe J; Hori K; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1983 Jun; 6(6):423-32. PubMed ID: 6631661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on a highly potent anticoagulant anionic high molecular weight fraction isolated from porcine heparin.
    Sache E; Choay J; Fareed J
    Ann N Y Acad Sci; 1981; 370():627-43. PubMed ID: 6943973
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-dependent disposition of fractionated 3H-heparin in rats.
    Watanabe J; Hori K; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1985 Jun; 8(6):468-76. PubMed ID: 4057042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant activity of heparin: assay of bovine, human and porcine preparations by amidolytic and clotting methods.
    Teien AN; Abildgaard U; Höök M; Lindahl U
    Thromb Res; 1977 Aug; 11(2):107-17. PubMed ID: 905965
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heparin clearance during activation of the anticoagulation system in animals].
    Ul'ianov AM
    Biull Eksp Biol Med; 1978 Jun; 85(6):651-4. PubMed ID: 667338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.